SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could fall sharply in 2027 has fueled concern about pricing and sales for CorMedixs flagship product, alongside a steep selloff. Traders disagree over whether the warning signals lasting pressure or is a preliminary, DaVita-specific estimate that overstates the risk; some view the decline as panic selling and point to CMS reimbursement figures as a counterpoint.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas selection for S&P 500 inclusion is drawing attention, with traders anticipating demand from index-tracking funds while debating whether that buying is already priced in and could be followed by profit-taking. The discussion also weighs the inclusion-driven momentum against concerns about Oktas valuation and slower growth.

NEOS ETF Trust - NEOS Nasdaq 100 High Income ETF

NEOS Nasdaq 100 High Income ETF

A broader market and Nasdaq-led tech selloff has pressured QQQI, prompting many holders to add on the dip while others raise cash or worry about further downside. The debate is set against the ETFs appeal as a high-income, monthly-distribution fund and concerns that covered-call exposure can limit upside or leave the fund vulnerable in a downturn.

Cameco Corp. engages in the provision of uranium. It operates through the following segments: Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Camecos Q3 report, including lower results and narrowed 2026 production guidance amid Cigar Lake production concerns, is driving the selloff. Traders are split between viewing the update and uranium-sector weakness as reasons for further downside and treating the pullback as an opportunity, citing long-term nuclear demand and firm uranium prices.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenus is drawing attention for encouraging early BOT+BAL immunotherapy data, including high pathologic response rates in a small Phase 2 colon cancer cohort and reported activity in sarcoma. The community is divided: bulls see potential for the treatment and its broader platform, while skeptics point to small, nonrandomized studies, the need for Phase 3 validation, and dilution and execution concerns.

Mattel, Inc. engages in the ownership of children's and family entertainment franchises. It operates through the following segments: North America, International, and American Girl. The North America and International segments focus on marketing and selling toys and consumer products. The American Girl segment includes marketing, retailing, and publishing dedicated to its mission to help girls grow up with confidence and character. The company was founded by Elliot Handler, Ruth Handler, and Harold Matson in 1945 and is headquartered in El Segundo, CA.

Mattel, Inc.

Reported takeover interest from Authentic Brands Group, alongside activist pressure for Mattel to consider a sale, is driving the discussion; no formal deal is confirmed. Traders are weighing potential acquisition upside against the risk that the takeover buzz fades without a firm bid.

United States Natural Gas Fund LP. - United States Natural Gas Fund

United States Natural Gas Fund, LP

Mild-weather forecasts and ample storage are weighing on natural gas prices by tempering expectations for heating demand. Traders are split between bearish views citing a potentially warm winter and surplus inventories, and dip-buyers betting on colder forecasts or a winter-driven rebound.

FuelCell Energy, Inc. is an American clean energy technology company that delivers continuous, scalable baseload power for mission-critical applications globally. It engages in the development, design, production, construction, operation, and servicing of high-temperature fuel cells for clean electric power generation. The company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emission power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems backed by global fuel cell deployments approaching one gigawatt. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FCEL is under pressure after traders criticized CEO Jason Fews Bloomberg appearance and flagged his expectation of a delay in signing the Texas definitive contract, alongside uncertainty about the promised 100 MW production ramp. Some investors remain focused on potential data-center demand and the Newport project, while others say execution delays and weak shareholder communication are undermining confidence.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

A newly disclosed convertible-note financing and proposed increase in authorized shares have fueled concerns about heavy dilution, triggering sharp selling and criticism of managements communication. Some traders see the funding as necessary to advance data-center projects, while others worry that ongoing cash needs could bring further dilution.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys better-than-expected quarterly results, supported by parks strength and improving streaming profitability, have renewed bullish interest and fueled breakout chatter. Traders remain divided, with optimists pointing to stronger execution and skeptics citing years of range-bound performance and nearby resistance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Creative Medical Extends Breakout as Patent Momentum Fuels Continued Buying Interest

Creative Medical (NASDAQ:CELZ) is continuing to attract investor attention after building on yesterday's patent-driven rally, with shares reaching an intraday high of $1.94 as momentum carried into a second trading session. The latest move follows news that the U.S. Patent and Trademark Office issued a Notice of Allowance for a new patent covering the company's exosome-based immunotherapy platform targeting Type 1 diabetes, further strengthening its growing intellectual property portfolio.

Creative Medical Looks to Extend Its Run as Diabetes Pipeline Expands

Creative Medical (NASDAQ:CELZ) could remain one to watch after attracting investor attention following yesterday’s reaction to news that the U.S. Patent and Trademark Office issued a Notice of Allowance for a new patent covering its exosome-based immunotherapy platform targeting Type 1 diabetes. The announcement added another layer of intellectual property protection to the company's expanding regenerative medicine portfolio and highlighted its strategy of building multiple therapeutic approaches aimed at one of the largest unmet needs in autoimmune disease.

Creative Medical Technology Stock Surges After Key Patent Win

Creative Medical Technology Holdings Inc. (NASDAQ: CELZ) shares are surging Thursday afternoon following an intellectual property milestone.read more...

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday's regular session. The company's market cap stands at $4.3 million.
Ensysce Biosciences (NASDAQ:ENSC) stock roseread more...

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million.
Caris Life Sciences (NASDAQ:CAI)read more...

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers

Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday's regular session. The market value of their outstanding shares is at $2.9 million.
Cuprina Holdings (Cayman)read more...

These Three Stocks Fell More Than 10% Today To Hit 52-Week Lows -- What's Driving The Investor Skepticism?

Equity

Creative Medical Technology, Baiya International Group, and GD Culture Group shares slumped to their 52-week lows amid divestiture and fundraising updates.

Bears are Losing Control Over Creative Medical Technology Holdings, Inc. (CELZ), Here's Why It's a 'Buy' Now

Creative Medical Technology Holdings, Inc. (CELZ) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Retail Traders Pile Into Creative Medical After FDA Fast Tracks Degenerative Disc Disease Therapy

The company estimates that the potential market for innovative treatments for spinal disorders could exceed $20 billion by 2030.

New Strong Sell Stocks for July 31st

CELZ, GRFS and WHR have been added to the Zacks Rank #5 (Strong Sell) List on July 31, 2025.

This account has been verified as an official CELZ representative.

Verified Account

CM Technology Holdings IR

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. Its products include CaverStem, FemCelz, StemSpine and ImmCelz. The company was founded by Timothy Warbington on December 3, 1998 and is headquartered in Phoenix, AZ.

Creative Medical Technology Holdings Inc

Bullish Sentiment

<ul class="summary-bullets"><li>Creative Medical Technology announced a public offering of up to 3.05 million shares of common stock.</li><li>GD Culture is set to implement a 1-for-250 reverse stock split on June 29.</li><li>Baiya International sold its entire stake in Juxing Investment Group (Hong Kong) to Shengshi International for $2 million.</li></ul>Shares of Creative Medical Technology Holdings Inc. (CELZ), Baiya International Group Inc. (BIYA), and GD Culture Group (GDC) slumped to their 52-week lows on Friday.At the time of writing, GDC shares were down more than 23%, BIYA stock fell around 14%, while CELZ stock tanked 33%.<h2 class="st-heading-2">CELZ To Offer 3M Shares</h2>Creative Medical Technology announced a best-efforts public offering of up to 3.05 million shares of common stock, or pre-funded warrants in lieu of shares for certain investors, together with warrants to purchase up to 6.09 million additional shares. The offering is priced at an assumed combined price of $1.97 per share, including the accompanying warrant.Despite the sharp slide, retail sentiment on Stocktwits for CELZ turned ‘bullish’ from ‘neutral’ over the past 24-hours, amid ‘extremely high’ message volumes. The stock has shed around 35% of its value so far in 2026.<a href="https://stocktwits.com/symbol/CELZ">CELZ stock</a> fell to as low as $1.20 on Friday.<h2 class="st-heading-2">GDC’s Reverse Stock Split, Share Offering In Spotlight</h2>GD Culture Group’s stock extended its descent after the company said it would implement a 1-for-250 reverse stock split on Thursday. The reverse split will be effective on June 29. Following the split, the company's outstanding shares will be reduced from about 1.04 billion to roughly 4.16 million.Prior to that, the company agreed to sell more than 259 million shares of common stock to certain investors, raising about $5.45 million in gross proceeds.Retail sentiment surrounding GDC on Stocktwits remained in the ‘bullish’ zone over the past 24 hours, while message volumes were ‘extremely high.’ The stock has plummeted more than 99% so far this year.<a href="https://stocktwits.com/symbol/GDC">GDC shares</a> hit an intraday low of $0.01.<h2 class="st-heading-2">BIYA Sells Entire Stake In Investment Group, Stock Struggles To Break $1</h2>According to an SEC filing, Baiya International Group sold its entire stake in Juxing Investment Group (Hong Kong) to Shengshi International Group for $2 million. <a href="https://stocktwits.com/symbol/BIYA">BIYA stock</a> crashed to an intraday low of $0.32.Retail sentiment on Stocktwits for BIYA remained in the ‘neutral’ territory over the past 24 hours. The stock fell under $1 on June 12 and has failed to reclaim the level since then. The firm had implemented a 1-for-30 reverse share split on Dec. 30, 2025. The stock has lost 92% so far this year.Also read: <a href="https://stocktwits.com/news-articles/markets/equity/capricor-dmd-study-update-fda-ad-com-capr-stock-falls/cZ1csymR7gD">Capricor’s Positive 5-Year Data For DMD Treatment Comes With A Regulatory Catch – CAPR Stock Slides 11%</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

Baiya International Group Inc. Ordinary Shares

GD Culture Group Limited

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.655
Prev Close	$0.6784
Open	$0.719
Dividend Yield	0.00%
50-Day Moving Average	$0.9305
Beta	1.04
Avg. Volume	1.21M
PE Ratio	-0.37

52-Week High	$4.72
52-Week Low	$0.62
Market Capitalization	$4.32M
EPS (Annual)	-$2.52
Price to Book	0.49
Revenue Per Employee	$1,500.00

Feed

News

Sentiment

Fundamentals

Info

CELZ Fundamentals